Telesis Bio, Inc.
Subcutaneous Delivery of Messenger RNA

Last updated:

Abstract:

The present invention provides, among other things, methods of formulating nucleic acid-containing nanoparticles with an mRNA encoding an enzyme to afford efficient delivery of payload to a cell or tissue of interest via subcutaneous administration. The resulting payload can be efficiently delivered to the liver and other organs or tissues of a treated subject.

Status:
Application
Type:

Utility

Filling date:

14 May 2019

Issue date:

22 Jul 2021